Kindred Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
3.10
58.00
146.00
155.00
475.00
1,129
Gross Income
3.10
58.00
146.00
155.00
475.00
837
SG&A Expense
4,216.20
27,175.00
27,116.00
22,014.00
31,178.00
52,093
EBIT
4,219.30
27,233.00
27,262.00
22,169.00
31,653.00
51,256
Unusual Expense
-
-
-
655.00
-
-
Non Operating Income/Expense
0.10
-
132.00
325.00
774.00
1,566
Pretax Income
4,213.40
27,139.00
27,130.00
22,499.00
30,879.00
49,690
Consolidated Net Income
4,213.40
27,139.00
27,130.00
22,499.00
30,879.00
49,690
Net Income
4,213.40
27,139.00
27,130.00
22,499.00
30,879.00
49,690
Net Income After Extraordinaries
4,213.40
27,139.00
27,130.00
22,499.00
30,879.00
49,690
Net Income Available to Common
4,213.40
27,139.00
27,130.00
22,499.00
30,879.00
49,690
EPS (Basic)
0.21
1.44
1.37
1.13
1.23
1.60
Basic Shares Outstanding
19,677.10
18,782.00
19,773.00
19,873.00
25,084.00
31,001
EPS (Diluted)
0.21
1.44
1.37
1.13
1.23
1.60
Diluted Shares Outstanding
19,677.10
18,782.00
19,773.00
19,873.00
25,084.00
31,001
EBITDA
4,216.20
27,175.00
27,116.00
22,014.00
31,178.00
50,451
Non-Operating Interest Income
6.00
94.00
-
-
-
-
About Kindred Biosciences
View Profile
